DK3452051T3 - COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN - Google Patents

COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN Download PDF

Info

Publication number
DK3452051T3
DK3452051T3 DK17792541.9T DK17792541T DK3452051T3 DK 3452051 T3 DK3452051 T3 DK 3452051T3 DK 17792541 T DK17792541 T DK 17792541T DK 3452051 T3 DK3452051 T3 DK 3452051T3
Authority
DK
Denmark
Prior art keywords
hmos
pain
treatment
composition
mast cell
Prior art date
Application number
DK17792541.9T
Other languages
English (en)
Inventor
Louise Kristine Vigsnæs
Bruce Mcconnell
Emma Elison
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/147,115 external-priority patent/US20160243139A1/en
Application filed by Glycom As filed Critical Glycom As
Application granted granted Critical
Publication of DK3452051T3 publication Critical patent/DK3452051T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17792541.9T 2016-05-05 2017-05-05 COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN DK3452051T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,115 US20160243139A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050146 WO2017190755A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain

Publications (1)

Publication Number Publication Date
DK3452051T3 true DK3452051T3 (en) 2022-09-05

Family

ID=60202799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17792541.9T DK3452051T3 (en) 2016-05-05 2017-05-05 COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN

Country Status (5)

Country Link
EP (1) EP3452051B1 (da)
DK (1) DK3452051T3 (da)
ES (1) ES2924137T3 (da)
PL (1) PL3452051T3 (da)
WO (1) WO2017190755A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11304966B2 (en) 2017-12-22 2022-04-19 Glycom A/S Composition comprising HMOs for preventing or reducing nociception
AU2020272575A1 (en) * 2019-04-09 2021-11-18 Intrinsic Medicine, Inc. Immunomodulatory oligosaccharides for the treatment of pain
EP4076474A4 (en) * 2019-12-06 2024-02-28 Glycom A/S COMPOSITION CONTAINING 2'-FL AND DFL FOR USE IN A PAIN RELIEF METHOD
WO2022117830A1 (en) * 2020-12-04 2022-06-09 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in a subject to support maturation of sleeping patterns

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
US8507227B2 (en) 2006-03-09 2013-08-13 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8852785B2 (en) 2009-03-05 2014-10-07 Nissan Motor Co., Ltd. Bipolar secondary battery and method for producing the same
AU2010223965A1 (en) * 2009-03-13 2011-10-06 Dsm Food Specialties Usa Inc. Prebiotic oligosaccharides
WO2010115935A1 (en) 2009-04-07 2010-10-14 Glycom A/S Synthesis of 2 ' -o-fucosyllactose
CN102803282A (zh) 2010-02-19 2012-11-28 格礼卡姆股份公司 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法
EP3369739A1 (en) * 2010-07-12 2018-09-05 The Regents of The University of California Bovine milk oligosaccharides
EP2593559A1 (en) 2010-07-16 2013-05-22 Glycom A/S Synthesis of new sialooligosaccharide derivatives
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
WO2012092160A2 (en) 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
CA2827294A1 (en) 2011-02-21 2012-08-30 Glycom A/S Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
JP2014510098A (ja) 2011-03-18 2014-04-24 グリコム アー／エス 新規のフコース含有炭水化物誘導体の合成
WO2012155916A1 (en) 2011-05-13 2012-11-22 Glycom A/S Manufacture of lacto-n-tetraose
JP2014513985A (ja) 2011-05-13 2014-06-19 グリコム アー／エス 人乳オリゴ糖（ｈｍｏ）又はその前駆体の形成方法
US9382564B2 (en) 2011-05-13 2016-07-05 Glycom A/S Diversification of human milk oligosaccharides (HMOs) or precursors thereof
CN103958537A (zh) 2011-09-30 2014-07-30 格礼卡姆股份公司 Hmo核心结构的合成
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
US20160243139A1 (en) * 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
JP7182872B2 (ja) * 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法
CN108348535B (zh) * 2015-10-28 2021-08-31 格礼卡姆股份公司 用于调节脑功能和行为的合成组合物和方法
US11357785B2 (en) * 2017-12-22 2022-06-14 Societe Des Produits Nestle S.A. Compositions for use in the reduction of nociception in infants and young children

Also Published As

Publication number Publication date
EP3452051A4 (en) 2020-01-08
EP3452051B1 (en) 2022-06-01
ES2924137T3 (es) 2022-10-04
EP3452051A1 (en) 2019-03-13
WO2017190755A1 (en) 2017-11-09
PL3452051T3 (pl) 2022-11-14

Similar Documents

Publication Publication Date Title
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancer and other medical disorders
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL261932A (en) Use of probiotics in the treatment and/or prevention of eczema
ZA201704726B (en) Peptides and their use in the treatment of skin
IL282836A (en) 5-halouracil - modified micro RNAs and their use in cancer treatment
DK3452051T3 (en) COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN
IL272414A (en) Use of gaboksadol in the treatment of diabetes and related conditions
GB201514021D0 (en) Novel Pyridines and their use in the treatment of cancer
DK3681857T3 (en) Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
IL270978B (en) Grape skin for use in the treatment of dysbiosis
ZA201801402B (en) SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE
GB201710822D0 (en) Methods and medical uses relating to the treatment of hypoglycaemia
LT3373922T (lt) Kompozicijos ir būdai skirti naudoti homocistinurijos gydyme
SG11201704486TA (en) Improvements in and relating to the treatment of matrices and/or the contents of matrices
EP3518951C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF OSTEOPOROSIS AND Fractures
EP3380112A4 (en) PEPTIDES AND THEIR USE IN THE TREATMENT OF HAIR
GB201514015D0 (en) Novel pyridazinones and their use in the treatment of cancer
SG11201802955VA (en) Peptides of use in the preventive and curative treatment of alopecia
IL261240B (en) Preparations useful in the prevention and/or treatment of inflammation and pain
PT3268378T (pt) Galactolípido para utilização na cicatrização de feridas e para utilização na prevenção e/ou tratamento do envelhecimento cutâneo
IL243402A0 (en) Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases
GB201421263D0 (en) Improvements in and relating to the treatment of matrices and/or the content ofmatrices